Allopurinol and Erythema multiforme - a phase IV clinical study of FDA data

Summary:

Erythema multiforme is found among people who take Allopurinol, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Allopurinol and have Erythema multiforme. It is created by eHealthMe based on reports of 164,051 people who have side effects when taking Allopurinol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 01, 2023

164,051 people reported to have side effects when taking Allopurinol.
Among them, 2,664 people (1.62%) have Erythema multiforme.

What is Allopurinol?

Allopurinol has active ingredients of allopurinol. It is often used in gout. eHealthMe is studying from 166,666 Allopurinol users for its effectiveness, alternative drugs and more.

What is Erythema multiforme?

Erythema multiforme (a type of hypersensitivity reaction) is found to be associated with 2,949 drugs and 2,835 conditions by eHealthMe.

Number of Allopurinol and Erythema multiforme reports submitted per year:

Could Allopurinol cause Erythema multiforme?

* Approximation only. Some reports may have incomplete information.

Do you take Allopurinol and have Erythema multiforme?

Check whether Erythema multiforme is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Tognetti L, Giorgini S, Lotti T, "Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction", Indian dermatology online journal, 2011 Jan .

Related studies

How severe was Erythema multiforme and when was it recovered:

Erythema multiforme in Allopurinol

Expand to all the drugs that have ingredients of allopurinol:

Erythema multiforme and drugs with ingredients of allopurinol (2,751 reports)

Alternative drugs to, pros and cons of Allopurinol:

Allopurinol (166,666 reports)

Common Allopurinol side effects:

Diarrhea: 9,701 reports
Fatigue (feeling of tiredness): 9,558 reports
Breathing difficulty: 8,893 reports
Weakness: 8,160 reports
Fever: 8,048 reports
Pneumonia: 7,430 reports

Browse all side effects of Allopurinol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Erythema multiforme treatments and more:

Erythema multiforme (51,191 reports)

COVID vaccines that are related to Erythema multiforme:

Common drugs associated with Erythema multiforme:

All the drugs that are associated with Erythema multiforme:

Erythema multiforme (2,949 drugs)

Common conditions associated with Erythema multiforme:

High blood pressure: 2,546 reports
Epilepsy: 1,791 reports
Fever: 1,545 reports
Pain: 1,525 reports
Depression: 1,255 reports

All the conditions that are associated with Erythema multiforme:

Erythema multiforme (2,835 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on allopurinol (the active ingredients of Allopurinol) and Allopurinol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.